Ethics of the allocation of highly advanced medical technologies.
The disproportionate distribution of financial, educational, social, and medical resources between some rich countries of the northern hemisphere and less fortunate societies creates a moral challenge of global dimension. The development of new forms of highly advanced medical technologies, including neoorgans and xenografts, as well as the promotion of health literacy and predictive and preventive medical services might reduce some problems in allocational justice. Most governments and the World Health Organization (WHO) reject financial and other rewards for living organ donors thus indirectly contributing to the development of black markets. A societal gratuity model supporting and safeguarding a highly regulated market between providers and recipients of organs might provide for better protection of those who provide organs not solely based on altruistic reasons. The moral assessment of global issues in allocation and justice in the distribution of medical technologies must be increased and will have to be based on the principles of self determination and responsibility, solidarity and subsidiarity, and respect for individual values and cultural traditions.
Sass
H M
HM
Zentrum fuer Medizinische Ethik, Ruhr Universitaet, Bochum, Germany.
D026683:Advisory Committees; D001187:Artificial Organs / Q000191:economics / Q000639:trends*; D001672:Biocompatible Materials; D018864:Cultural Diversity; D019049:Developed Countries; D003906:Developing Countries; D004992:Ethics, Medical; D006266:Health Education / Q000639:trends*; D006801:Humans; D038622:Internationality; D016377:Organ Transplantation / Q000191:economics / Q000639:trends*; D040841:Resource Allocation; D012926:Social Control, Formal; D012959:Socioeconomic Factors; D014019:Tissue Donors; D009927:Tissue and Organ Procurement; D014183:Transplantation, Heterologous
D001672:Biocompatible Materials